ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Solifenacin Succinate Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-17I10587
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Solifenacin Succinate Drug Market Report Forecast 2022 2028
BUY CHAPTERS

Global Solifenacin Succinate Drug Market Research Report 2025

Code: QYRE-Auto-17I10587
Report
September 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma
TEVA
Ajanta Pharma
Aurobindo Pharma
Glenmark Pharmaceuticals
Qilu Pharmaceutical
Cipla Ltd
Jiangxi Boya Seehot Pharmaceutical
Crescent Pharma
VESICARE

Solifenacin Succinate Drug Market Size

The global market for Solifenacin Succinate Drug was valued at US$ 47.7 million in the year 2024 and is projected to reach a revised size of US$ 63.4 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Solifenacin Succinate Drug Market

Solifenacin Succinate Drug Market

Solifenacin is used to treat an overactive bladder.
Solifenacin succinate is a medication used for the treatment of overactive bladder, a condition characterized by urinary urgency, frequency, and incontinence. The global market for Solifenacin succinate is influenced by several driving factors. Here are some key drivers of the Solifenacin succinate market: Increasing prevalence of overactive bladder: Overactive bladder is a common urological condition affecting millions of people worldwide. As the prevalence of overactive bladder continues to rise, the demand for medications like Solifenacin succinate is expected to increase. Aging population: The global population is aging, and older adults are more prone to bladder problems, including overactive bladder. With a larger elderly population, there is a growing need for treatments like Solifenacin succinate to manage their symptoms and improve their quality of life. Growing awareness and diagnosis of overactive bladder: Improved awareness and better diagnostic methods have led to increased recognition of overactive bladder among patients. This increased awareness results in more individuals seeking medical help and receiving appropriate treatments like Solifenacin succinate. Advancements in healthcare infrastructure and technology: Advancements in healthcare infrastructure and technology have improved the diagnosis and treatment of overactive bladder. These advancements contribute to the growth of the Solifenacin succinate market by facilitating better patient care and medication administration. Expansion of indications: Solifenacin succinate is being evaluated for its potential use in other conditions beyond overactive bladder, such as nocturia (excessive nighttime urination) and neurogenic detrusor overactivity. If approved for these expanded indications, Solifenacin succinate"s market demand is expected to increase. Rising healthcare expenditure: Increasing healthcare expenditure globally has improved access and affordability of medications, including Solifenacin succinate. This allows more patients to seek appropriate treatment for their overactive bladder symptoms.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Solifenacin Succinate Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solifenacin Succinate Drug.
The Solifenacin Succinate Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solifenacin Succinate Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solifenacin Succinate Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Solifenacin Succinate Drug Market Report

Report Metric Details
Report Name Solifenacin Succinate Drug Market
Accounted market size in year US$ 47.7 million
Forecasted market size in 2031 US$ 63.4 million
CAGR 4.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 5 mg Tablet
  • 10 mg Tablet
Segment by Application
  • Hospital
  • Drug store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma, Teva, Ajanta Pharma, Aurobindo Pharma, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Cipla, Jiangxi Boya Seehot Pharmaceutical, Crescent Pharma, VESICARE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Solifenacin Succinate Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Solifenacin Succinate Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Solifenacin Succinate Drug Market growing?

Ans: The Solifenacin Succinate Drug Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Solifenacin Succinate Drug Market size in 2031?

Ans: The Solifenacin Succinate Drug Market size in 2031 will be US$ 63.4 million.

Who are the main players in the Solifenacin Succinate Drug Market report?

Ans: The main players in the Solifenacin Succinate Drug Market are Astellas Pharma, Teva, Ajanta Pharma, Aurobindo Pharma, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Cipla, Jiangxi Boya Seehot Pharmaceutical, Crescent Pharma, VESICARE

What are the Application segmentation covered in the Solifenacin Succinate Drug Market report?

Ans: The Applications covered in the Solifenacin Succinate Drug Market report are Hospital, Drug store

What are the Type segmentation covered in the Solifenacin Succinate Drug Market report?

Ans: The Types covered in the Solifenacin Succinate Drug Market report are 5 mg Tablet, 10 mg Tablet

Recommended Reports

Urinary & Bladder Care

Succinate-Related Drugs

Urological & Antispasmodics

1 Solifenacin Succinate Drug Market Overview
1.1 Product Definition
1.2 Solifenacin Succinate Drug by Type
1.2.1 Global Solifenacin Succinate Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.3 Solifenacin Succinate Drug by Application
1.3.1 Global Solifenacin Succinate Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Solifenacin Succinate Drug Market Size Estimates and Forecasts
1.4.1 Global Solifenacin Succinate Drug Revenue 2020-2031
1.4.2 Global Solifenacin Succinate Drug Sales 2020-2031
1.4.3 Global Solifenacin Succinate Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Solifenacin Succinate Drug Market Competition by Manufacturers
2.1 Global Solifenacin Succinate Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Solifenacin Succinate Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Solifenacin Succinate Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Solifenacin Succinate Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Solifenacin Succinate Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Solifenacin Succinate Drug, Product Type & Application
2.7 Global Key Manufacturers of Solifenacin Succinate Drug, Date of Enter into This Industry
2.8 Global Solifenacin Succinate Drug Market Competitive Situation and Trends
2.8.1 Global Solifenacin Succinate Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Solifenacin Succinate Drug Players Market Share by Revenue
2.8.3 Global Solifenacin Succinate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Solifenacin Succinate Drug Market Scenario by Region
3.1 Global Solifenacin Succinate Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Solifenacin Succinate Drug Sales by Region: 2020-2031
3.2.1 Global Solifenacin Succinate Drug Sales by Region: 2020-2025
3.2.2 Global Solifenacin Succinate Drug Sales by Region: 2026-2031
3.3 Global Solifenacin Succinate Drug Revenue by Region: 2020-2031
3.3.1 Global Solifenacin Succinate Drug Revenue by Region: 2020-2025
3.3.2 Global Solifenacin Succinate Drug Revenue by Region: 2026-2031
3.4 North America Solifenacin Succinate Drug Market Facts & Figures by Country
3.4.1 North America Solifenacin Succinate Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Solifenacin Succinate Drug Sales by Country (2020-2031)
3.4.3 North America Solifenacin Succinate Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Solifenacin Succinate Drug Market Facts & Figures by Country
3.5.1 Europe Solifenacin Succinate Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Solifenacin Succinate Drug Sales by Country (2020-2031)
3.5.3 Europe Solifenacin Succinate Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Solifenacin Succinate Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Solifenacin Succinate Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Solifenacin Succinate Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Solifenacin Succinate Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Solifenacin Succinate Drug Market Facts & Figures by Country
3.7.1 Latin America Solifenacin Succinate Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Solifenacin Succinate Drug Sales by Country (2020-2031)
3.7.3 Latin America Solifenacin Succinate Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Solifenacin Succinate Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Solifenacin Succinate Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Solifenacin Succinate Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Solifenacin Succinate Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Solifenacin Succinate Drug Sales by Type (2020-2031)
4.1.1 Global Solifenacin Succinate Drug Sales by Type (2020-2025)
4.1.2 Global Solifenacin Succinate Drug Sales by Type (2026-2031)
4.1.3 Global Solifenacin Succinate Drug Sales Market Share by Type (2020-2031)
4.2 Global Solifenacin Succinate Drug Revenue by Type (2020-2031)
4.2.1 Global Solifenacin Succinate Drug Revenue by Type (2020-2025)
4.2.2 Global Solifenacin Succinate Drug Revenue by Type (2026-2031)
4.2.3 Global Solifenacin Succinate Drug Revenue Market Share by Type (2020-2031)
4.3 Global Solifenacin Succinate Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Solifenacin Succinate Drug Sales by Application (2020-2031)
5.1.1 Global Solifenacin Succinate Drug Sales by Application (2020-2025)
5.1.2 Global Solifenacin Succinate Drug Sales by Application (2026-2031)
5.1.3 Global Solifenacin Succinate Drug Sales Market Share by Application (2020-2031)
5.2 Global Solifenacin Succinate Drug Revenue by Application (2020-2031)
5.2.1 Global Solifenacin Succinate Drug Revenue by Application (2020-2025)
5.2.2 Global Solifenacin Succinate Drug Revenue by Application (2026-2031)
5.2.3 Global Solifenacin Succinate Drug Revenue Market Share by Application (2020-2031)
5.3 Global Solifenacin Succinate Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Company Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Pharma Solifenacin Succinate Drug Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Solifenacin Succinate Drug Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Ajanta Pharma
6.3.1 Ajanta Pharma Company Information
6.3.2 Ajanta Pharma Description and Business Overview
6.3.3 Ajanta Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ajanta Pharma Solifenacin Succinate Drug Product Portfolio
6.3.5 Ajanta Pharma Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Company Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aurobindo Pharma Solifenacin Succinate Drug Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Company Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Glenmark Pharmaceuticals Solifenacin Succinate Drug Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Company Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qilu Pharmaceutical Solifenacin Succinate Drug Product Portfolio
6.6.5 Qilu Pharmaceutical Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Solifenacin Succinate Drug Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Jiangxi Boya Seehot Pharmaceutical
6.8.1 Jiangxi Boya Seehot Pharmaceutical Company Information
6.8.2 Jiangxi Boya Seehot Pharmaceutical Description and Business Overview
6.8.3 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product Portfolio
6.8.5 Jiangxi Boya Seehot Pharmaceutical Recent Developments/Updates
6.9 Crescent Pharma
6.9.1 Crescent Pharma Company Information
6.9.2 Crescent Pharma Description and Business Overview
6.9.3 Crescent Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Crescent Pharma Solifenacin Succinate Drug Product Portfolio
6.9.5 Crescent Pharma Recent Developments/Updates
6.10 VESICARE
6.10.1 VESICARE Company Information
6.10.2 VESICARE Description and Business Overview
6.10.3 VESICARE Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 VESICARE Solifenacin Succinate Drug Product Portfolio
6.10.5 VESICARE Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Solifenacin Succinate Drug Industry Chain Analysis
7.2 Solifenacin Succinate Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Solifenacin Succinate Drug Production Mode & Process Analysis
7.4 Solifenacin Succinate Drug Sales and Marketing
7.4.1 Solifenacin Succinate Drug Sales Channels
7.4.2 Solifenacin Succinate Drug Distributors
7.5 Solifenacin Succinate Drug Customer Analysis
8 Solifenacin Succinate Drug Market Dynamics
8.1 Solifenacin Succinate Drug Industry Trends
8.2 Solifenacin Succinate Drug Market Drivers
8.3 Solifenacin Succinate Drug Market Challenges
8.4 Solifenacin Succinate Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astellas Pharma
TEVA
Ajanta Pharma
Aurobindo Pharma
Glenmark Pharmaceuticals
Qilu Pharmaceutical
Cipla Ltd
Jiangxi Boya Seehot Pharmaceutical
Crescent Pharma
VESICARE
List of Tables
 Table 1. Global Solifenacin Succinate Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Solifenacin Succinate Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Solifenacin Succinate Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Solifenacin Succinate Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Solifenacin Succinate Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Solifenacin Succinate Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Solifenacin Succinate Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Solifenacin Succinate Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Solifenacin Succinate Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Solifenacin Succinate Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Solifenacin Succinate Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Solifenacin Succinate Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Solifenacin Succinate Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solifenacin Succinate Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Solifenacin Succinate Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Solifenacin Succinate Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Solifenacin Succinate Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Solifenacin Succinate Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Solifenacin Succinate Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Solifenacin Succinate Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Solifenacin Succinate Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Solifenacin Succinate Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Solifenacin Succinate Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Solifenacin Succinate Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Solifenacin Succinate Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Solifenacin Succinate Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Solifenacin Succinate Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Solifenacin Succinate Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Solifenacin Succinate Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Solifenacin Succinate Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Solifenacin Succinate Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Solifenacin Succinate Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Solifenacin Succinate Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Solifenacin Succinate Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Solifenacin Succinate Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Solifenacin Succinate Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Solifenacin Succinate Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Solifenacin Succinate Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Solifenacin Succinate Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Solifenacin Succinate Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Solifenacin Succinate Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Solifenacin Succinate Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Solifenacin Succinate Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Solifenacin Succinate Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Solifenacin Succinate Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Solifenacin Succinate Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Solifenacin Succinate Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Solifenacin Succinate Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Solifenacin Succinate Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Solifenacin Succinate Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Solifenacin Succinate Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Solifenacin Succinate Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Solifenacin Succinate Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Solifenacin Succinate Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Solifenacin Succinate Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Solifenacin Succinate Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Solifenacin Succinate Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Solifenacin Succinate Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Solifenacin Succinate Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Solifenacin Succinate Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Solifenacin Succinate Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Solifenacin Succinate Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Solifenacin Succinate Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Solifenacin Succinate Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Solifenacin Succinate Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Solifenacin Succinate Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Solifenacin Succinate Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Solifenacin Succinate Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Astellas Pharma Company Information
 Table 71. Astellas Pharma Description and Business Overview
 Table 72. Astellas Pharma Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Astellas Pharma Solifenacin Succinate Drug Product
 Table 74. Astellas Pharma Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Solifenacin Succinate Drug Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Ajanta Pharma Company Information
 Table 81. Ajanta Pharma Description and Business Overview
 Table 82. Ajanta Pharma Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Ajanta Pharma Solifenacin Succinate Drug Product
 Table 84. Ajanta Pharma Recent Developments/Updates
 Table 85. Aurobindo Pharma Company Information
 Table 86. Aurobindo Pharma Description and Business Overview
 Table 87. Aurobindo Pharma Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Aurobindo Pharma Solifenacin Succinate Drug Product
 Table 89. Aurobindo Pharma Recent Developments/Updates
 Table 90. Glenmark Pharmaceuticals Company Information
 Table 91. Glenmark Pharmaceuticals Description and Business Overview
 Table 92. Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Glenmark Pharmaceuticals Solifenacin Succinate Drug Product
 Table 94. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 95. Qilu Pharmaceutical Company Information
 Table 96. Qilu Pharmaceutical Description and Business Overview
 Table 97. Qilu Pharmaceutical Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Qilu Pharmaceutical Solifenacin Succinate Drug Product
 Table 99. Qilu Pharmaceutical Recent Developments/Updates
 Table 100. Cipla Company Information
 Table 101. Cipla Description and Business Overview
 Table 102. Cipla Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Cipla Solifenacin Succinate Drug Product
 Table 104. Cipla Recent Developments/Updates
 Table 105. Jiangxi Boya Seehot Pharmaceutical Company Information
 Table 106. Jiangxi Boya Seehot Pharmaceutical Description and Business Overview
 Table 107. Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product
 Table 109. Jiangxi Boya Seehot Pharmaceutical Recent Developments/Updates
 Table 110. Crescent Pharma Company Information
 Table 111. Crescent Pharma Description and Business Overview
 Table 112. Crescent Pharma Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Crescent Pharma Solifenacin Succinate Drug Product
 Table 114. Crescent Pharma Recent Developments/Updates
 Table 115. VESICARE Company Information
 Table 116. VESICARE Description and Business Overview
 Table 117. VESICARE Solifenacin Succinate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. VESICARE Solifenacin Succinate Drug Product
 Table 119. VESICARE Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Solifenacin Succinate Drug Distributors List
 Table 123. Solifenacin Succinate Drug Customers List
 Table 124. Solifenacin Succinate Drug Market Trends
 Table 125. Solifenacin Succinate Drug Market Drivers
 Table 126. Solifenacin Succinate Drug Market Challenges
 Table 127. Solifenacin Succinate Drug Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Solifenacin Succinate Drug
 Figure 2. Global Solifenacin Succinate Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Solifenacin Succinate Drug Market Share by Type: 2024 & 2031
 Figure 4. 5 mg Tablet Product Picture
 Figure 5. 10 mg Tablet Product Picture
 Figure 6. Global Solifenacin Succinate Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Solifenacin Succinate Drug Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug store
 Figure 10. Global Solifenacin Succinate Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Solifenacin Succinate Drug Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Solifenacin Succinate Drug Sales (2020-2031) & (K Units)
 Figure 13. Global Solifenacin Succinate Drug Average Price (USD/Unit) & (2020-2031)
 Figure 14. Solifenacin Succinate Drug Report Years Considered
 Figure 15. Solifenacin Succinate Drug Sales Share by Manufacturers in 2024
 Figure 16. Global Solifenacin Succinate Drug Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Solifenacin Succinate Drug Players: Market Share by Revenue in Solifenacin Succinate Drug in 2024
 Figure 18. Solifenacin Succinate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Solifenacin Succinate Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Solifenacin Succinate Drug Sales Market Share by Country (2020-2031)
 Figure 21. North America Solifenacin Succinate Drug Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Solifenacin Succinate Drug Sales Market Share by Country (2020-2031)
 Figure 25. Europe Solifenacin Succinate Drug Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Solifenacin Succinate Drug Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Solifenacin Succinate Drug Revenue Market Share by Region (2020-2031)
 Figure 33. China Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Solifenacin Succinate Drug Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Solifenacin Succinate Drug Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Solifenacin Succinate Drug Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Solifenacin Succinate Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Solifenacin Succinate Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Solifenacin Succinate Drug by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Solifenacin Succinate Drug by Type (2020-2031)
 Figure 55. Global Solifenacin Succinate Drug Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Solifenacin Succinate Drug by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Solifenacin Succinate Drug by Application (2020-2031)
 Figure 58. Global Solifenacin Succinate Drug Price (USD/Unit) by Application (2020-2031)
 Figure 59. Solifenacin Succinate Drug Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Solifenacin Succinate API Market Research Report 2024
Global Solifenacin Succinate Tablets Market Research Report 2024
Global Overactive Bladder Medication Market Insights Forecast to 2030
Global OAB Treatment Market Research Report 2025
Flecainide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mirabegron API Market Research Report 2024
Global Overactive Bladder Drug Market Research Report 2024
Propiverine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oxybutynin Transdermal System Market Insights Forecast to 2030
Global Metoprolol Succinate API Market Research Report 2025
Global Milnacipran Market Insights Forecast to 2030
Lisinopril Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sucralfate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treprostinil Drugs Market Insights Forecast to 2030
Benign Prostatic Hyperplasia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Staphylococcal Infection Treatment Market Insights Forecast to 2030
Global Overactive Bladder OAB Bionic Drug Market Research Report 2025
Sumatriptan Succinate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rufinamide Market Insights Forecast to 2030
Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions